Inozyme Pharma's activity chart (see below) currently has 46 price targets and 53 ratings on display.
Analysts' price targets on this stock were met 19.05% of the time, taking 9.29 days on average.
Most recent stock forecast was given by TIAGO FAUTH from RAYMOND JAMES on 19-May-2025. First documented stock forecast 18-Aug-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 19-May-2025
$4
$9
1 years 6 months 3 days ago
(19-May-2025)
1/3 (33.33%)
$0.01 (0.25%)
38
Buy Since 29-Nov-2021
$12
1 years 6 months 6 days ago
(16-May-2025)
0/12 (0%)
$8.05 (203.80%)
Buy Since 07-Feb-2022
1 years 7 months 12 days ago
(10-Apr-2025)
0/9 (0%)
$9.77 (230.97%)
Buy Since 18-Aug-2020
$7
$15
1 years 8 months 12 days ago
(10-Mar-2025)
0/7 (0%)
$5.94 (560.38%)
Buy Since 04-May-2021
$40
1 years 10 months 9 days ago
(13-Jan-2025)
0/2 (0%)
$34.55 (633.94%)
What is INZY (Inozyme Pharma) average time for price targets to be met?
Which analyst most recently updated their price target on INZY (Inozyme Pharma)?
Which analyst has the lowest performance score on INZY (Inozyme Pharma) with a proven track record?
Which analyst has the most public recommendations on INZY (Inozyme Pharma)?
Which analyst is the currently most bullish on INZY (Inozyme Pharma)?
Which analyst is the currently most reserved on INZY (Inozyme Pharma)?